rosiglitazone has been researched along with acrolein in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Chen, YJ; Feng, YL; Liu, DS; Liu, WJ; Ou, XM; Wang, T; Wen, FQ; Xu, D; Zhang, SF | 1 |
Fan, MS; Huang, CG; Li, ZX; Sun, ZL; Tang, YH | 1 |
2 other study(ies) available for rosiglitazone and acrolein
Article | Year |
---|---|
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Topics: Acrolein; Animals; Blotting, Western; Bronchoalveolar Lavage Fluid; Cytokines; Drug Interactions; Goblet Cells; Immunohistochemistry; Lung Diseases; Male; Mucin 5AC; NF-kappa B; PPAR gamma; Random Allocation; Rats; Rats, Sprague-Dawley; Respiratory Mucosa; Reverse Transcriptase Polymerase Chain Reaction; RNA; Rosiglitazone; Thiazolidinediones | 2009 |
Anti-diabetic effects of TongGuanWan, a Chinese traditional herbal formula, in C57BL/KsJ-db/db mice.
Topics: Acrolein; Administration, Oral; Animals; Berberine; Blood Glucose; Body Weight; Cholesterol, HDL; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Glucose Intolerance; Glycated Hemoglobin; Hypoglycemic Agents; Lipids; Male; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, Knockout; Phytotherapy; Rosiglitazone; Saponins; Thiazolidinediones; Triglycerides; Xanthones | 2012 |